Related Experiment Video
Updated: Jul 7, 2026

Drug-Induced Sleep Endoscopy (DISE) with Target Controlled Infusion (TCI) and Bispectral Analysis in Obstructive Sleep Apnea
Published on: December 6, 2016
Epidemiology of pediatric obstructive sleep apnea
Julie C Lumeng1, Ronald D Chervin
1Center for Human Growth and Development, and Department of Pediatrics, University of Michigan, Ann Arbor, MI 48109-0406, USA. jlumeng@umich.edu
Insights
Pediatric obstructive sleep apnea (OSA) affects many children, with prevalence ranging from 1% to 4%. Research highlights challenges in diagnosing sleep-disordered breathing (SDB) in kids.
Area of Science:
- Pediatric Sleep Medicine
- Epidemiology
- Respiratory Medicine
Background:
- Pediatric obstructive sleep apnea (OSA) is increasingly recognized as a significant childhood health issue.
- Epidemiology and clinical features of pediatric OSA differ from adult OSA.
- The spectrum of pediatric sleep-disordered breathing (SDB) ranges from primary snoring to OSA.
Purpose of the Study:
- To systematically review studies on the epidemiology of pediatric SDB.
- To identify methodologic challenges in pediatric SDB research.
- To estimate the population prevalence of pediatric SDB and OSA.
Main Methods:
- Systematic review of studies on pediatric SDB and OSA epidemiology.
- Analysis of data on snoring, apneic events, and diagnostic criteria.
- Meta-analysis of parent-reported snoring prevalence.
Main Results:
- Estimated prevalence of habitual snoring: 1.5% to 6%.
- Estimated prevalence of parent-reported apneic events: 0.2% to 4%.
- Estimated prevalence of SDB (questionnaire-based): 4% to 11%.
- Estimated prevalence of OSA (diagnostic criteria-based): 1% to 4%.
- Overall snoring prevalence (meta-analysis): 7.45%.
- SDB appears more common in boys, heavier children, and possibly African American children.
Conclusions:
- Methodologic variability presents challenges in pediatric SDB/OSA epidemiology.
- Prevalence estimates for pediatric SDB and OSA vary widely due to differing diagnostic criteria.
- Future research should address these methodologic limitations to better understand pediatric SDB epidemiology.
Abstract:
Pediatric obstructive sleep apnea (OSA) has become widely recognized only in the last few decades as a likely cause of significant morbidity among children. Many of the clinical characteristics of pediatric OSA, and the determinants of its epidemiology, differ from those of adult OSA. We systematically reviewed studies on the epidemiology of conditions considered part of a pediatric sleep-disordered breathing (SDB) continuum, ranging from primary snoring to OSA. We highlight a number of methodologic challenges, including widely variable methodologies for collection of questionnaire data about symptomatology, definitions of habitual snoring, criteria for advancing to further diagnostic testing, and objective diagnostic criteria for SDB or OSA. In the face of these limitations, estimated population prevalences are as follows: parent-reported "always" snoring, 1.5 to 6%; parent-reported apneic events during sleep, 0.2 to 4%; SDB by varying constellations of parent-reported symptoms on questionnaire, 4 to 11%; OSA diagnosed by varying criteria on diagnostic studies, 1 to 4%. Overall prevalence of parent-reported snoring by any definition in meta-analysis was 7.45% (95% confidence interval, 5.75-9.61). A reasonable preponderance of evidence now suggests that SDB is more common among boys than girls, and among children who are heavier than others, with emerging data to suggest a higher prevalence among African Americans. Less convincing data exist to prove differences in prevalence based on age. We conclude by outlining specific future research needs in the epidemiology of pediatric SDB.
Related Concept Videos
Sleep Apnea
The condition is more prevalent among...
Other Pulmonary Disorders
Chronic Obstructive Pulmonary Disease I: Introduction
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Pharmacokinetics in Pediatric Patients: Drug Metabolism
